Analyst Trung Huynh from UBS asked about potential ACIP policy changes ... s focus on operational efficiency, capital allocation, and strategic R&D shifts positions Pfizer to navigate ...

Digital fluency and change Looking back now, the rate of change still astounds. Way back in January 2020, Pfizer’s 2019 annual report could only note the potential disruption from a novel strain ...

Despite a 6% revenue drop, Pfizer Inc (PFE) focuses on R&D advancements, cost savings, and dividend growth to drive future success.

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer ( PFE 2.20%) and Medical Properties Trust ( MPW -0.10%).

risks related to the successful integration of the licensed asset with Pfizer’s business; disruption from the transaction making it more difficult to maintain business and operational ...

Albert Bourla, Chairman and CEO of Pfizer: "We continued ... References to operational variances pertain to period-over-period changes that exclude the impact of foreign exchange rates (5).